Praziquantel Treatment of Individuals Exposed toSchistosoma haematobiumEnhances Serological Recognition of Defined Parasite Antigens
Author(s) -
Francisca Mutapi,
Richard Burchmore,
Takafira Mduluza,
Aude Foucher,
Yvonne Harcus,
Gavin Nicoll,
Nicholas Midzi,
C. Michael R. Turner,
Rick M. Maizels
Publication year - 2005
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/432553
Subject(s) - praziquantel , schistosoma haematobium , serology , parasite hosting , schistosomiasis , immunology , helminthiasis , antigen , schistosoma , medicine , parasitic disease , disease , antibody , biology , schistosoma mansoni , virology , helminths , world wide web , computer science
Schistosomiasis is a major parasitic disease affecting >200 million people in the developing world, and 400 million people are at risk for infection. This study aimed to identify and compare proteins recognized by serum samples from schistosome-exposed individuals before and after curative praziquantel treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom